Beijing Leadman Biochemistry Co.,Ltd. (SHE:300289)

Market Cap	3.00B +15.2%
Revenue (ttm)	317.86M -10.3%
Net Income	-25.70M
EPS	-0.05
Shares Out	544.01M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,516,702
Open	5.61
Previous Close	5.52
Day's Range	5.51 - 6.62
52-Week Range	4.92 - 11.67
Beta	0.04
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About SHE:300289

Beijing Leadman Biochemistry Co.,Ltd. researches and develops, manufactures, and sells vitro diagnostic reagents and instruments, and biochemical raw materials in the People’s Republic of China. The company offers biochemical raw materials, including enzymes, antigens, coenzymes, antibodies, buffers, enzyme substrates, culture mediums, stain agents, amino acids, and other products for biotechnology, clinical diagnosis, drug development, chemical production, and other related applications. It also provides biochemical reagents for liver function...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1997
• Employees: 420
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300289

Financial Performance

In 2025, SHE:300289's revenue was 326.31 million, a decrease of -11.86% compared to the previous year's 370.23 million. Losses were -22.98 million, -69.40% less than in 2024.